retatrutide launch date Availability & Timeline eli lilly retatrutide release date

In June, Canadian health officials approved a generic version of Novo Nordisks Wegovy medication to be used as a treatment for weight loss

Glucagon activation: Increases hepatic energy expenditure and fat oxidation

Medicare/Medicaid: Under these landmark agreements, many government-insured patients will see monthly copays capped at $50

As of September 2025, GLP-1 drugs were priced at nearly $1K per month, although these costs are expected to fall to as low as $350 or less due to price agreements between GLP-1 companies and the Trump administration

Eur Med J (2015) 3(1):5765

While these products are often marketed as GLP-1 patches or needle-free alternatives, theyre fundamentally different from medical treatments